1. Home
  2. ALXO vs TOUR Comparison

ALXO vs TOUR Comparison

Compare ALXO & TOUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ALX Oncology Holdings Inc.

ALXO

ALX Oncology Holdings Inc.

HOLD

Current Price

$1.41

Market Cap

79.7M

Sector

Health Care

ML Signal

HOLD

Logo Tuniu Corporation

TOUR

Tuniu Corporation

HOLD

Current Price

$0.76

Market Cap

87.0M

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALXO
TOUR
Founded
2015
2006
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Transportation Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
79.7M
87.0M
IPO Year
2020
2014

Fundamental Metrics

Financial Performance
Metric
ALXO
TOUR
Price
$1.41
$0.76
Analyst Decision
Strong Buy
Analyst Count
6
0
Target Price
$3.30
N/A
AVG Volume (30 Days)
350.9K
107.9K
Earning Date
11-07-2025
12-05-2025
Dividend Yield
N/A
4.79%
EPS Growth
N/A
N/A
EPS
N/A
0.03
Revenue
N/A
$75,532,120.00
Revenue This Year
N/A
$12.27
Revenue Next Year
N/A
$10.18
P/E Ratio
N/A
$22.37
Revenue Growth
N/A
7.57
52 Week Low
$0.40
$0.70
52 Week High
$2.27
$1.17

Technical Indicators

Market Signals
Indicator
ALXO
TOUR
Relative Strength Index (RSI) 50.42 41.41
Support Level $1.29 $0.71
Resistance Level $1.56 $0.77
Average True Range (ATR) 0.14 0.04
MACD 0.00 0.00
Stochastic Oscillator 48.91 29.69

Price Performance

Historical Comparison
ALXO
TOUR

About ALXO ALX Oncology Holdings Inc.

ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials. Cancer cells leverage CD47, a cell surface protein, as a don't eat me signal to evade detection by the immune system. The company is developing a next-generation checkpoint inhibitor designed to have a high affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches.

About TOUR Tuniu Corporation

Tuniu Corp is an online leisure travel company. The company is engaged in the provision of travel-related services in the People's Republic of China. It offers a large selection of packaged tours, including organized tours and self-guided tours, as well as travel-related services for leisure travelers. The company's organized tours provide pre-arranged itineraries, transportation, accommodations, entertainment, meals, and tour guide services. Its self-guided tours consist of combinations of flights and hotel bookings and other optional add-ons. The company derives almost all of its revenue from PRC.

Share on Social Networks: